Nephrotoxic mechanisms of f low-rank coal (lignite) leachates in drinking water
Nephrotoxic mechanisms of f low-rank coal (lignite) leachates in drinking water
批准号:
10082452
负责人:
Michael A. Ihnat
金额:
$7.25万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-01-08 至 2023-06-30
关键词:
AddressAnimalsAreaArkansasBalkan NephropathyBalkansBladderBloodBosnia-HerzegovinaBrainBulgariaCell DeathChemicalsCoalComplete Blood CountCountyCreatinineCroatiaDegenerative DisorderDepositionDiseaseDoseEnd stage renal failureEnvironmental Risk FactorEtiologyExposure toFemaleGeographyGeologyGoalsHealthHeartHexanesHot SpringsIncidenceInductively Coupled Plasma Mass SpectrometryInflammationKidneyKidney DiseasesLinkLiverLouisianaLungMalignant NeoplasmsMass FragmentographyMediatingMetalsMethanolMicroscopicNatureOklahomaOrganOsmolalitiesPathologistPhaseProcessPublishingRattusRecording of previous eventsRenal functionRomaniaRuralSamplingSerbiaSerumSkinSolidSpleenSprague-Dawley RatsTestingTexasToxic effectToxicokineticsUniversitiesUrea NitrogenUrineUrotheliumWater consumptionWeightWorkaqueouscytotoxiccytotoxicitydrinking watergraduate studentgulf coastin vivokidney cellmalenephrotoxicityrenal damageundergraduate student
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Balkan endemic nephropathy (BEN) is a degenerative disease that is often associated with urothelial cancer and
is geographically confined to rural parts of Serbia, Bulgaria, Romania, Croatia, and Bosnia. The etiology of BEN
is debated, and several environmental factors have been considered as contributors to the disease. The Pliocene
lignite hypothesis links BEN and exposure to organic material in drinking water that is leached from a low-rank
coal known as lignite. This hypothesis addresses the limited geographic nature of BEN, as most of the villages
plagued with the disease are also closely associated with lignite deposits. We and others have shown an
association of lignite deposits in the southeastern US with renal cell toxicity in culture and with an increased
incidence of end-stage renal disease (ESRD).The overall goal of the studies in this work are to test the specific
hypothesis that environmental levels of U.S. Gulf Coast region lignite aqueous extracts in drinking water result
in BEN-like nephrotoxicity in vivo. Aim 1 will test the prediction that drinking water exposure to lignite coal
extracts from the southeastern US results in a dose-dependent nephrotoxicity. In this study, male and female
Sprague-Dawley (S-D) rats will be exposed to environmental levels of coal extracts in their drinking water for six
months. Samples will be either lignite extracts found to be toxic to renal cells (Dolet Hills, LA and Monticello,
TX); or lignite extracts found to be less toxic to kidney cells (San Miguel, TX; Hot Springs County, AR). Water
intake, animal weights and general health will be assessed weekly. Blood and 24 hr urine will be collected at 3
and 6 months from a subset of animals and assessed for renal function markers (urine osmolality, NAG levels;
serum urea nitrogen and creatinine). Kidneys will be assessed for toxicity, cell death and inflammation grossly
and microscopically by a veterinary pathologist as will other potential target organs (bladder, lungs, heart, liver,
spleen, brain, skin, complete blood count). Aim 2 will test the prediction that lignite degradation products,
specifically polar organic compounds, are cytotoxic to renal cells. In this aim, toxic extracts (Dolet Hills, LA;
Monticello, TX) will be separated by solid-phase extraction followed by a two-step elution process to generate a
non-polar component (compounds soluble in hexane) and polar component (compounds soluble in methanol).
These fractions applied at various concentrations as in our preliminary work to HK-2 and RPTEC/TERT1 renal
cells and assessed for cytotoxicity. The impact of this proposal is to begin to tie these two findings together,
namely to test whether lignite coal extracts in the drinking water of rats is nephrotoxic and to begin to understand
the lignite components/mechanisms mediating this nephrotoxicity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Drugs Targeting Dormant Tumors as Anti-Metastatic Agents
-
批准号:8338890
-
项目类别:
-
资助金额:$87.17万
-
财政年份:2008
-
负责人:Michael A. Ihnat
-
依托单位:
Drugs Targeting Dormant Tumors as Anti-Metastatic Agents
-
批准号:7537741
-
项目类别:
-
资助金额:$12.25万
-
财政年份:2008
-
负责人:Michael A. Ihnat
-
依托单位:
Drugs Targeting Dormant Tumors as Anti-Metastatic Agents
-
批准号:8203484
-
项目类别:
-
资助金额:$110.25万
-
财政年份:2008
-
负责人:Michael A. Ihnat
-
依托单位:
COBRE: HIF-1 AS THERAPEUTIC TARGET IN DIABETIC RETINOPATHY
-
批准号:7381937
-
项目类别:
-
资助金额:$10.73万
-
财政年份:2006
-
负责人:Michael A. Ihnat
-
依托单位:
COBRE: HIF-1 AS THERAPEUTIC TARGET IN DIABETIC RETINOPATHY
-
批准号:7171157
-
项目类别:
-
资助金额:$15.11万
-
财政年份:2005
-
负责人:Michael A. Ihnat
-
依托单位:
COBRE: HIF-1: THERAPEUTIC TARGET IN DIABETIC RETINOPATHY
-
批准号:6982234
-
项目类别:
-
资助金额:$21.03万
-
财政年份:2004
-
负责人:Michael A. Ihnat
-
依托单位:
海外基金